Article
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis
2025-07-29
Abstract excerpt
Half of advanced melanoma patients fail to benefit from immune checkpoint blockade and novel treatments are urgently required. Testing topical medications used in other skin diseases for anti-cancer activity in an immunotherapy-resistant murine melanoma model, we counterintuitively found that glucocorticoids elicit rapid cytotoxic T lymphocyte (CTL)-dependent tumor control. Genetic ablation of the glucocorticoid r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 35d8d4d3-e10c-5044-8eb9-63be0451b1b4
- DOI
- 10.1101/2025.07.24.666619
